Skip to main content
Loading

Beyond ASOs & siRNA: Advancing Next-Generation Oligonucleotide Modalities for Enhanced Therapeutic Impact

26 Jun 2025
New Modalities
  • Exploring new platforms such as DNAzymes, aptamers, and circular RNAs for enhanced stability and function

  • Innovations in conjugation, lipid nanoparticles (LNPs), and extrahepatic targeting strategies

  • Defining characterization, quality control, and safety evaluation standards for next-gen therapeutics